| Year |
Citation |
Score |
| 2020 |
Moyer SM, Wasylishen AR, Qi Y, Fowlkes N, Su X, Lozano G. p53 drives a transcriptional program that elicits a non-cell-autonomous response and alters cell state in vivo. Proceedings of the National Academy of Sciences of the United States of America. PMID 32900967 DOI: 10.1073/Pnas.2008474117 |
0.392 |
|
| 2020 |
Wasylishen AR, Sun C, Moyer SM, Qi Y, Chau GP, Aryal NK, McAllister F, Kim MP, Barton MC, Estrella JS, Su X, Lozano G. Daxx maintains endogenous retroviral silencing and restricts cellular plasticity in vivo. Science Advances. 6: eaba8415. PMID 32821827 DOI: 10.1126/Sciadv.Aba8415 |
0.403 |
|
| 2020 |
Wasylishen AR, Sun C, Chau GP, Qi Y, Su X, Kim MP, Estrella JS, Lozano G. Men1 maintains exocrine pancreas homeostasis in response to inflammation and oncogenic stress. Proceedings of the National Academy of Sciences of the United States of America. PMID 32156729 DOI: 10.1073/Pnas.1920017117 |
0.327 |
|
| 2020 |
El Beaino M, Liu J, Wasylishen AR, Pourebrahim R, Migut A, Bessellieu BJ, Huang K, Lin PP. Loss of Stag2 cooperates with EWS-FLI1 to transform murine Mesenchymal stem cells. Bmc Cancer. 20: 3. PMID 31898537 DOI: 10.1186/S12885-019-6465-8 |
0.34 |
|
| 2019 |
Pant V, Xiong S, Wasylishen AR, Larsson CA, Aryal NK, Chau G, Tailor RC, Lozano G. Transient enhancement of p53 activity protects from radiation-induced gastrointestinal toxicity. Proceedings of the National Academy of Sciences of the United States of America. PMID 31409715 DOI: 10.1073/Pnas.1909550116 |
0.302 |
|
| 2019 |
Samdani RT, Wasylishen AR, Halperin DM, Dasari A, Yao JC, Rashid A, Estrella JS. Loss of Menin Expression by Immunohistochemistry in Pancreatic Neuroendocrine Tumors: Comparison Between Primary and Metastatic Tumors. Pancreas. PMID 30946241 DOI: 10.1097/Mpa.0000000000001274 |
0.32 |
|
| 2019 |
Aryal NK, Pant V, Wasylishen AR, Rimel B, Baseler L, El-Naggar AK, Mutch DG, Goodfellow PJ, Arur S, Lozano G. Dicer1 phospho-mimetic promotes tumor progression and dissemination. Cancer Research. PMID 30914430 DOI: 10.1158/0008-5472.Can-18-2460 |
0.403 |
|
| 2019 |
Ding J, Li X, Zhang C, Gao F, Wu S, Wasylishen A, Baggerly K, Lozano G, Koul D, Yung A. CBMT-32. EGFR SUPPRESSES p53 FUNCTION THROUGH DNA-PKcs BINDING TO p53: NOVEL CROSSTALK BETWEEN EGFR AND TP53 IN GLIOBLASTOMA Neuro-Oncology. 21: vi40-vi40. DOI: 10.1093/Neuonc/Noz175.154 |
0.329 |
|
| 2018 |
Aryal NK, Pant V, Wasylishen AR, Parker-Thornburg J, Baseler L, El-Naggar AK, Liu B, Kalia A, Lozano G, Arur S. Constitutive Dicer1 phosphorylation accelerates metabolism and aging in vivo. Proceedings of the National Academy of Sciences of the United States of America. PMID 30593561 DOI: 10.1073/Pnas.1814377116 |
0.309 |
|
| 2018 |
Wasylishen AR, Estrella JS, Pant V, Chau GP, Lozano G. Daxx Functions are p53-independent In Vivo. Molecular Cancer Research : McR. PMID 29903771 DOI: 10.1158/1541-7786.Mcr-18-0281 |
0.386 |
|
| 2018 |
Tonnessen-Murray C, Ungerleider NA, Rao SG, Wasylishen AR, Frey WD, Jackson JG. p53 Mediates Vast Gene Expression Changes That Contribute to Poor Chemotherapeutic Response in a Mouse Model of Breast Cancer. Translational Oncology. 11: 930-940. PMID 29852458 DOI: 10.1016/J.Tranon.2018.05.003 |
0.442 |
|
| 2017 |
Aryal NK, Wasylishen AR, Pant V, Riley-Croce M, Lozano G. Loss of digestive organ expansion factor (Diexf) reveals an essential role during murine embryonic development that is independent of p53. Oncotarget. 8: 103996-104006. PMID 29262616 DOI: 10.18632/Oncotarget.22087 |
0.346 |
|
| 2016 |
Wasylishen AR, Lozano G. Attenuating the p53 Pathway in Human Cancers: Many Means to the Same End. Cold Spring Harbor Perspectives in Medicine. PMID 27329033 DOI: 10.1101/Cshperspect.A026211 |
0.417 |
|
| 2016 |
Li L, Liang S, Wasylishen AR, Zhang Y, Yang X, Zhou B, Shan L, Han X, Mu T, Wang G, Xiong S. PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway. Oncotarget. PMID 26933804 DOI: 10.18632/Oncotarget.7694 |
0.45 |
|
| 2015 |
Lourenco C, Wasylishen A, Chan-Seng-Yue M, Bros C, Dingar D, Tu W, Kalkat M, Chan P, Mullen P, Raught B, Boutros P, Penn L. Abstract A10: The myc post-translational landscape: How novel gain-of-function mutants are revealing new stability and functional regulatory systems Molecular Cancer Research. 13. DOI: 10.1158/1557-3125.Myc15-A10 |
0.631 |
|
| 2015 |
Kalkat M, Chan P, Wasylishen AR, Srikumar T, Kim SS, Ponzielli R, Bazett-Jones DP, Raught B, Penn LZ. Abstract A08: Identification of c-MYC SUMOylation by mass spectrometry Molecular Cancer Research. 13. DOI: 10.1158/1557-3125.Myc15-A08 |
0.64 |
|
| 2014 |
Kalkat M, Chan PK, Wasylishen AR, Srikumar T, Kim SS, Ponzielli R, Bazett-Jones DP, Raught B, Penn LZ. Identification of c-MYC SUMOylation by mass spectrometry. Plos One. 9: e115337. PMID 25522242 DOI: 10.1371/Journal.Pone.0115337 |
0.628 |
|
| 2014 |
Xiong S, Tu H, Kollareddy M, Pant V, Li Q, Zhang Y, Jackson JG, Suh YA, Elizondo-Fraire AC, Yang P, Chau G, Tashakori M, Wasylishen AR, Ju Z, Solomon H, et al. Pla2g16 phospholipase mediates gain-of-function activities of mutant p53. Proceedings of the National Academy of Sciences of the United States of America. 111: 11145-50. PMID 25024203 DOI: 10.1073/Pnas.1404139111 |
0.34 |
|
| 2014 |
Goard CA, Chan-Seng-Yue M, Mullen PJ, Quiroga AD, Wasylishen AR, Clendening JW, Sendorek DH, Haider S, Lehner R, Boutros PC, Penn LZ. Identifying molecular features that distinguish fluvastatin-sensitive breast tumor cells. Breast Cancer Research and Treatment. 143: 301-12. PMID 24337703 DOI: 10.1007/S10549-013-2800-Y |
0.703 |
|
| 2014 |
Wasylishen AR, Kalkat M, Kim SS, Pandyra A, Chan PK, Oliveri S, Sedivy E, Konforte D, Bros C, Raught B, Penn LZ. MYC activity is negatively regulated by a C-terminal lysine cluster. Oncogene. 33: 1066-72. PMID 23435422 DOI: 10.1038/Onc.2013.36 |
0.656 |
|
| 2014 |
Wasylishen AR, Lozano G. Abstract 3917: Understanding the mechanisms driving pancreatic neuroendocrine tumorigenesis Cancer Research. 74: 3917-3917. DOI: 10.1158/1538-7445.Am2014-3917 |
0.399 |
|
| 2013 |
Wasylishen AR, Chan-Seng-Yue M, Bros C, Dingar D, Tu WB, Kalkat M, Chan PK, Mullen PJ, Huang L, Meyer N, Raught B, Boutros PC, Penn LZ. MYC phosphorylation at novel regulatory regions suppresses transforming activity. Cancer Research. 73: 6504-15. PMID 24030976 DOI: 10.1158/0008-5472.Can-12-4063 |
0.642 |
|
| 2011 |
Wasylishen AR, Stojanova A, Oliveri S, Rust AC, Schimmer AD, Penn LZ. New model systems provide insights into Myc-induced transformation. Oncogene. 30: 3727-34. PMID 21441954 DOI: 10.1038/Onc.2011.88 |
0.63 |
|
| 2011 |
Kalkat M, Wasylishen AR, Kim SS, Penn L. More than MAX: Discovering the Myc interactome. Cell Cycle (Georgetown, Tex.). 10: 374-5. PMID 21270515 DOI: 10.4161/Cc.10.3.14645 |
0.582 |
|
| 2011 |
Mullen PJ, Goard CA, Wasylishen AR, Pandyra A, Penn LZ. Abstract C165: Breast cancer, statins, and 3-D cell culture. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-C165 |
0.705 |
|
| 2010 |
Wasylishen AR, Penn LZ. Myc: the beauty and the beast. Genes & Cancer. 1: 532-41. PMID 21779457 DOI: 10.1177/1947601910378024 |
0.579 |
|
| 2010 |
Luoto KR, Meng AX, Wasylishen AR, Zhao H, Coackley CL, Penn LZ, Bristow RG. Tumor cell kill by c-MYC depletion: role of MYC-regulated genes that control DNA double-strand break repair. Cancer Research. 70: 8748-59. PMID 20940401 DOI: 10.1158/0008-5472.Can-10-0944 |
0.625 |
|
| 2010 |
Wong WW, Boutros PC, Wasylishen AR, Guckert KD, O'Brien EM, Griffiths R, Martirosyan AR, Bros C, Jurisica I, Langler RF, Penn LZ. Characterization of the apoptotic response of human leukemia cells to organosulfur compounds. Bmc Cancer. 10: 351. PMID 20598143 DOI: 10.1186/1471-2407-10-351 |
0.61 |
|
| 2008 |
Beheshti Zavareh R, Lau KS, Hurren R, Datti A, Ashline DJ, Gronda M, Cheung P, Simpson CD, Liu W, Wasylishen AR, Boutros PC, Shi H, Vengopal A, Jurisica I, Penn LZ, et al. Inhibition of the sodium/potassium ATPase impairs N-glycan expression and function. Cancer Research. 68: 6688-97. PMID 18701493 DOI: 10.1158/0008-5472.Can-07-6833 |
0.576 |
|
| Show low-probability matches. |